News
05-23-2016, 12:37 AM
The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab.
More... (http://www.news-medical.net/news/20160523/DECT-trial-shows-combination-of-epirubicin-and-trastuzumab-improves-outcomes-in-breast-cancer-patients.aspx)
More... (http://www.news-medical.net/news/20160523/DECT-trial-shows-combination-of-epirubicin-and-trastuzumab-improves-outcomes-in-breast-cancer-patients.aspx)